Transcat Stock Price and Value Analysis

Transcat (NasdaqGM:TRNS) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Transcat to reach your target.

Target type

TRNS Free Cash Flow Trend

Free Cash Flow trendline for TRNS
Free Cash Flow trendline for Transcat
CSV

Based on historical returns, we believe that Transcat can grow its free cash at a rate of about 6%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the TRNS Numbers

TRNS Price
(Transcat stock price per share)
$99.65
[?] TRNS Fair Price
(based on intrinsic value)
$31.96
[?] TRNS Safety Price (based on a variable margin of safety) $19.18
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 1162% higher than other Technology stocks
[?] PE Ratio versus Industry 582% higher than other Scientific & Technical Instruments stocks
[?] Free Cash Flow Jitter 48%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 378,791 shares shorted. With 9,168,878 shares available for purchase and an average trading volume over the past 10 trading days of 239,330, it would take at least 1.6 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2010 99302
2011 99302
2012 99302
2013 99302
2014 99302
2015 99302
2016 99302
2017 99302
2018 99302
2019 99302
2020 99302
2021 99302
2022 99302
2023 99302
2024 99302
2025 99302
2026 99302

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2010 to 2026 with positive net income, operating cash flow totaled $249.0 million against net income of $112.4 million, or 2.21 times.

In 2026, operating cash flow was 6.48 times net income, compared with 1.92 times for the earliest three years (2010 to 2012).

In 2026, capital expenditures were $15.3 million, 43.9% of operating cash flow of $34.9 million, which leaves an estimated $19.6 million after capex. Across the 17 years with reported capex, it averaged 43.8% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2010 1.5 5.6 1.1 3.89
2011 2.8 2.6 1.6 0.92
2012 3.3 6.3 1.4 1.90
2013 3.7 5.2 2.7 1.41
2014 4.0 7.6 2.0 1.91
2015 4.0 4.4 3.5 1.10
2016 4.1 11.0 4.1 2.66
2017 4.5 7.5 5.2 1.67
2018 5.9 9.9 5.9 1.67
2019 7.1 12.6 7.0 1.76
2020 8.1 11.6 6.6 1.43
2021 7.8 23.6 6.6 3.03
2022 11.4 17.6 10.2 1.55
2023 10.7 17.0 9.4 1.59
2024 13.6 32.6 13.3 2.39
2025 14.5 39.0 13.2 2.69
2026 5.4 34.9 15.3 6.48

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2017 to 2026 with dividend or share repurchase facts, estimated free cash flow totaled $134.2 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In 6 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $21.4 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2017 4.1 n/a 0.1 0.1 2.4%
2018 5.7 n/a 0.4 0.4 6.3%
2019 7.4 n/a 0.1 0.1 2.0%
2020 5.8 n/a 2.8 2.8 48.7%
2021 17.4 n/a 3.0 3.0 17.5%
2022 10.4 n/a 6.7 6.7 64.4%
2023 9.0 n/a 0.4 0.4 5.0%
2024 23.4 n/a 4.9 4.9 21.0%
2025 28.5 n/a 3.6 3.6 12.5%
2026 22.6 n/a 0.5 0.5 2.1%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $81.1 million in 2010 and $331.9 million in 2026, a compound annual growth rate of 9.2% over 16 years.

Revenue rose 19.2% from 2025 to 2026.

Our estimated free cash flow was $22.6 million in 2026, 6.8% of revenue. In 2010 the estimated margin was 5.6%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2010 81.1 4.5 5.6%
2011 91.2 1.2 1.3%
2012 110.0 4.9 4.4%
2013 112.3 3.5 3.1%
2014 118.5 5.9 4.9%
2015 123.6 2.2 1.8%
2016 122.2 8.3 6.8%
2017 143.9 4.1 2.8%
2018 155.1 5.7 3.7%
2019 160.9 7.4 4.6%
2020 173.1 5.8 3.4%
2021 173.3 17.4 10.0%
2022 205.0 10.4 5.1%
2023 230.6 9.0 3.9%
2024 259.5 23.4 9.0%
2025 278.4 28.5 10.2%
2026 331.9 22.6 6.8%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2026, cash and equivalents were $4.9 million against total liabilities of $179.9 million, or 2.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 37.4% of total assets in 2026, compared with 43.6% in 2011, a decrease of 6.2 percentage points.

Stockholders equity was $300.6 million in 2026, compared with $23.3 million in 2011, a rise of 1188.6%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 5.2% in 2026. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2011 41.4 0.0 18.0 23.3
2012 45.0 0.0 17.6 27.4
2013 55.0 0.4 23.4 31.6
2014 53.9 0.0 23.8 30.1
2015 62.1 0.1 27.8 34.3
2016 76.7 0.6 37.8 38.9
2017 92.1 0.8 48.7 43.4
2018 96.8 0.6 45.5 51.3
2019 105.2 0.8 45.6 59.6
2020 128.1 0.5 61.0 67.1
2021 132.1 0.6 57.0 75.1
2022 177.8 1.4 91.6 86.2
2023 195.7 1.5 96.1 99.6
2024 287.6 19.6 62.4 225.2
2025 385.2 1.5 98.4 286.9
2026 480.5 4.9 179.9 300.6

Price Versus Our Estimated Value

Every one of the 17 fiscal years we have for Transcat under its current filer shows positive free cash flow.

Comparing the first and last three years of data, average free cash flow rose sharply: $3.5 million at the start and $24.8 million most recently.

Free cash flow is volatile from year to year, with a variability measure of 48%.

At $99.65, Transcat trades above our fair value estimate of $31.96.

No dividend yield is recorded for Transcat in our data.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 1162% above the average for stocks in the Technology sector.

Its trailing P/E ratio is 582% above the average for stocks in the Scientific & Technical Instruments industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 99302.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2026
Price and market data last refreshed
2026-11-18
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: TRNS annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in TRNS

Does Transcat have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: TRNS

This example shows how we apply the Trendshare checklist to TRNS: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 99.65
    • Market cap: $937M
    • EPS: 0.48
  2. Step 2 — Valuation checks

    • P/E: 207.604
    • FCF yield: —
    • Date checked: Nov 18, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.